Integra LifeSciences | IART - 销售成本



金融业
股票价格
USD
资产
USD 3.58B
现金及等价物
USD 236.81M
销售成本
USD 178.71M
流动资产
USD 1.17B
流动负债
USD 346.85M
债务
USD 2.04B
EBIT
USD 11.47M
EBITDA
USD 76.18M
员工
4.4K
EPS每股收益
USD 0.54
股本和储备
USD 1.04B
销售毛利
USD 213.21M
债务利息支出
USD 22.47M
利息收入
USD 4.11M
贷款资金
USD 1.83B
市值
USD 1.38B
净收入
USD -4.62M
营业费用
USD 1.04B
营业利润
USD 11.47M
普通股股本
USD 77.82M
PE价格收益
5.07
税前利润
USD -2.41M
销售收入
USD 391.9M
销售和管理费用
USD 178.24M
股票
USD 495.04M
贸易债权人
USD 87.95M
应收帐款人
USD 264.41M


销售成本 更改 日
Abbott USD 5.3B 380M 2026-03
AtriCure USD 31.94M 3.22M 2026-03
Baxter International USD 1.81B 587M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
CONMED USD 133.6M 21.31M 2026-03
Cooper Companies USD 393.8M 17M 2026-03
Dexcom USD 441.6M 25.3M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Globus Medical USD 263.59M 26.88M 2026-03
Insulet USD 232.7M 17.5M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Medtronic USD 3.8B 195M 2026-03
Merit Medical Systems USD 197.08M 1.5M 2026-03
Orthofix International USD 66.63M 6.4M 2025-12
Smith & Nephew USD 870M 17M 2025-12
Stryker USD 2.36B 325M 2026-03
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 240.84M 20.7M 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03